ABALOS THERAPEUTICS
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.
ABALOS THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Essen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.abalos-tx.com
Total Employee:
11+
Status:
Active
Contact:
+49 201 565 787-00
Email Addresses:
[email protected]
Total Funding:
43 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Nginx Euro
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hx Bio Ventures
Hx Bio Ventures investment in Series A - Abalos Therapeutics
coparion
coparion investment in Series A - Abalos Therapeutics
Seventure Partners
Seventure Partners investment in Series A - Abalos Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Abalos Therapeutics
Ventura BioMed Investors
Ventura BioMed Investors investment in Series A - Abalos Therapeutics
Gruenderfonds Ruhr
Gruenderfonds Ruhr investment in Series A - Abalos Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics
NRW.BANK
NRW.BANK investment in Series A - Abalos Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Abalos Therapeutics
Official Site Inspections
http://www.abalos-tx.com
- Host name: 201.208.204.92.host.secureserver.net
- IP address: 92.204.208.201
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "Abalos Therapeutics"
Abalos Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +49 201 565 787-00 The company intends to use the funds to advance its arenavirus-based lead …See details»
Org Chart Abalos Therapeutics - The Official Board
The organizational chart of Abalos Therapeutics displays its 10 main executives including Gerben Moolhuizen. Toggle navigation The Official Board. Search. Search. Search by segment. ...See details»
Abalos Therapeutics 2025 Company Profile: Valuation, …
Abalos Therapeutics General Information Description. Developer of a novel immuno-virotherapy designed for the treatment of cancer. The company's …See details»
News & Events – ABALOS THERAPEUTICS
Oct 14, 2021 Abalos Therapeutics Appoints Gerben Moolhuizen as Chief Executive Officer. Read full Press Release here. 18 March 2024 Abalos selected for funding project by KMU …See details»
Abalos Therapeutics Appoints Gerben Moolhuizen as Chief …
In immuno-oncology. For more information, please visit www.abalos-tx.com. For more information, please contact: Abalos Therapeutics GmbH Phone: +49 211 540104-0 Email: info@abalos …See details»
ABALOS DISTRIBUTING COMP INC Company Profile | Houston, TX ...
Find company research, competitor information, contact details & financial data for ABALOS DISTRIBUTING COMP INC of Houston, TX. Get the latest business insights from Dun & …See details»
Abalos Therapeutics Appoints Gerben Moolhuizen as Chief
Oct 9, 2024 For more information, please visit www.abalos-tx.com. Contacts. Abalos Therapeutics GmbH Phone: +49 211 540104-0 Email: [email protected]. Abalos media …See details»
Abalos Technologies - VentureRadar
" Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power …See details»
Abalos Therapeutics - Startbase
Abalos Therapeutics uses the unique immune stimulation of arena viruses to develop a new approach to fight cancer. This will enable the full power of the entire immune system to be …See details»
Abalos Therapeutics Company Information - Funding, Investors, …
See Abalos Therapeutics company profile and funding data. Mentioned on: FEATURED IN. Startups Discover startups. Startup Rankings. Discover the fastest growing tech startups …See details»
Abalos Therapeutics - Golden
Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005. Overview Structured Data Issues Contributors Activity. Contents. abalos-tx.com. Is a. Organization. Company. …See details»
Abalos Therapeutics - startbase.de
Official Website: abalos-tx.com; On Social Media: Juristische Person: Abalos Therapeutics GmbH Bundesland: Nordrhein-Westfalen Übersicht Unternehmen Finanzierung Produkt Team …See details»
Hx Bio invests in Abalos Therapeutics to develop an arenavirus …
Oct 14, 2021 Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology. For more information, please visit …See details»
Abalos Technologies - VentureRadar
Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types …See details»
PRESS RELEASE - abalos-tx.com
Oct 15, 2019 Abalos Therapeutics GmbH Marcus Kostka, PhD, CEO Phone: +49 201 565 787-00 Email: [email protected] Abalos media inquiries Trophic Communications Gretchen …See details»
abalos-tx.com - ABALOS THERAPEUTICS – Novel An... - ABALOS Tx …
Abalos-tx.com provides SSL-encrypted connection. ADULT CONTENT INDICATORS Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored …See details»
THE APPROACH – ABALOS THERAPEUTICS
Abalos is leveraging its unique AdaptInnate approach in a new class of product candidates harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to trigger a …See details»
ACLU of Texas Announces Four New Board Members
Aug 18, 2022 Feliz Abalos is an attorney born and raised in Odessa, Texas. After law school at Ohio Northern University, she quickly returned to the Permian Basin to begin her career in …See details»
Publications – ABALOS THERAPEUTICS
2019 Viral infection overcomes ineffectiveness of anti-tumoral CD8+ T cell mediated cytotoxicitySee details»